Table 2. Groups of the ATC a classification more used by adults and older adults for the treatment of chronic diseases according to funding source of the medicines (free of charge or paid of out-of-pocket). PNAUM, Brazil, 2014.
| ATC classification levels 1 and 2 | Funding source of the medicine | |||
|---|---|---|---|---|
|
| ||||
| % paidb | 95%CI | % freeb | 95%CI | |
| A: Digestive apparatus and metabolism | ||||
| A10 Medicine used for diabetes | 21.4 | 18.7–24.4 | 78.6 | 75.6–81.3 |
| C: Cardiovascular system | ||||
| C01 Cardiac therapy | 56.2 | 49.5–62.6 | 43.8 | 37.4–50.5 |
| C02 Antihypertensives | 50.4 | 41.7–59.1 | 49.6 | 40.9–58.3 |
| C03 Diuretics | 22.0 | 19.5–24.8 | 78.0 | 75.2–80.5 |
| C07 Beta-blockers | 37.3 | 34.2–40.6 | 62.7 | 59.4–65.8 |
| C0 Calcium channel blockers | 41.4 | 36.3–46.7 | 58.6 | 53.3–63.7 |
| C09 Agents acting on the renin-angiotensin system | 26.6 | 24.2–29.2 | 73.4 | 70.8–75.8 |
| C10 Lipids modifier agents | 44.6 | 40.7–48.6 | 55.4 | 51.4–59.3 |
| N: Nervous system | ||||
| N06 Psychoanaleptics | 41.5 | 37.5–45.6 | 58.5 | 54.4–62.5 |
| N03 Antiepileptics | 41.2 | 36.0–46.7 | 58.8 | 53.3–64.0 |
| N05 Psycholeptics | 45.3 | 39.1–51.6 | 54.7 | 48.4–60.9 |
| N04 Antiparkinson | 26.4 | 17.2–38.2 | 73.6 | 61.8–82.8 |
| R: Respiratory system | ||||
| R03 Agents against airway obstructive diseases | 60.0 | 52.7–66.9 | 40.0 | 33.1–47.3 |
| R06 Antihistamines for systemic use | 56.6 | 43.3–69.1 | 43.4 | 30.9–56.7 |